865589-89-5

Basic information

• Product Name: N-adamantan-1-yl-2-{3-[(R)-2-((R)-1-phenyl-ethylamino)-propyl]-phenyl}-acetamide
• Synonyms: N-adamantan-1-yl-2-{3-[(R)-2-((R)-1-phenyl-ethylamino)-propyl]-phenyl}-acetamide
• CAS NO: 865589-89-5
• Molecular Weight: 430.634
• Mol File: 865589-89-5.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: N-adamantan-1-yl-2-{3-[(R)-2-((R)-1-phenyl-ethylamino)-propyl]-phenyl}-acetamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-adamantan-1-yl-2-{3-[(R)-2-((R)-1-phenyl-ethylamino)-propyl]-phenyl}-acetamide(865589-89-5)
• EPA Substance Registry System: N-adamantan-1-yl-2-{3-[(R)-2-((R)-1-phenyl-ethylamino)-propyl]-phenyl}-acetamide(865589-89-5)

Safety Data

• Hazardous Substances Data: 865589-89-5(Hazardous Substances Data)

Upstream product

• 865589-88-4 [3-((2R)-2-{[(1R)-1-phenyl-ethyl]-amino}-propyl)-phenyl]-acetic acid 
• 768-94-5 1-Adamantanamine 

Downstream Products

• 865589-90-8 N-adamantan-1-yl-2-[3-((R)-2-amino-propyl)-phenyl]-acetamide 

Relevant articles and documents

The discovery of adamantyl-derived, inhaled, long acting β2-adrenoreceptor agonists

The design and profile of a series of adamantyl-containing long acting β2-adrenoreceptor agonists are described. An optimal pharmacokinetic profile of low oral bioavailability was combined with a strong pharmacology profile when assessed using

Compounds for the treatment of diseases

The invention relates to compounds of formula (1) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The compounds according to the present invention are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.